Greentank Technologies receives cannabis research license as a vape manufacturer
Cannabis research license granted to first vape hardware manufacturer
TORONTO — Greentank Technologies Corp. announced on Dec. 3 that it has received Health Canada approval for a cannabis research license. This marks the first time a cannabis research license has been granted to any vape hardware manufacturer globally, and opens up the opportunity for Greentank to take an industry leadership role in the advancement of vape reliability, performance and safety.
Under the research license, Greentank can handle up to 10,000 grams of dried cannabis flower or 2,500 grams of cannabis extract for research purposes at the company’s headquarters in Toronto, Canada. This allows the company to comprehensively test its partners’ extracts in house for viscosity, fluidity, constituents, emissions and the various ways those extracts interact with different materials and hardware technologies to determine the best fits for each brand’s formulations.
The research license also allows Greentank to import cannabis from legal foreign suppliers and conduct focus-group studies with its brand partners. This data will provide consumer feedback around taste, performance and user experience, as well as critical data surrounding vape emissions and interactions with various materials. Greentank expects its newly expanded research mandate will drastically shorten design cycles and accelerate product development by allowing the company to validate new hardware technologies more efficiently than ever before.
“As the only vape hardware manufacturer in the world able to legally conduct formulation testing and research, Greentank is uniquely positioned to lead the way in regulatory compliance adoption.” says Greentank CEO, Dustin Koffler.
The announcement coincides with Greentank’s construction of its third vape device lab, a state-of-the-art product engineering and development hub operated under the stewardship of Greentank Chief Engineer and former Dyson engineering manager Pete Duckett.
“It’s become clear that one-size-fits-all approaches do not work for THC delivery. This research license provides us with a tremendous opportunity to transform our approach to customization and hardware development to create safer, higher-performing next-generation technologies,” says Pete Duckett.